Arbutus to present at jefferies virtual london healthcare conference

Warminster, penn., nov. 10, 2020 (globe newswire) -- arbutus biopharma corporation (nasdaq: abus), a clinical-stage biopharmaceutical company primarily focused on developing a cure for people with chronic hepatitis b virus (hbv) infection, as well as therapies to treat coronaviruses (including covid-19), today announced that william collier, arbutus' president and chief executive officer, will present at the jefferies virtual london healthcare conference on tuesday, november 17, 2020 at 12:35 pm est (5:35 pm gmt).
ABUS Ratings Summary
ABUS Quant Ranking